Willis Investment Counsel Maxcyte, Inc. Transaction History
Willis Investment Counsel
- $1.45 Billion
- Q1 2025
A detailed history of Willis Investment Counsel transactions in Maxcyte, Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 380,471 shares of MXCT stock, worth $1.11 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
380,471
Previous 405,471
6.17%
Holding current value
$1.11 Million
Previous $1.69 Million
38.43%
% of portfolio
0.07%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
70.6MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$27.2 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$23.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$15.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$14.7 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$12.8 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $296M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...